Fengate Private Equity has invested in eMAX Health to enhance its growth trajectory and strengthen its position in the healthcare sector.

Information on the Target

eMAX Health, founded in 2004 by Julian Casciano, has emerged as a prominent leader in the domain of real-world evidence development research, market access, and patient services. The company boasts a highly qualified team composed of research scientists, healthcare professionals, and key opinion leaders, all supported by advanced data management systems and technology-driven solutions. eMAX Health has developed proprietary platforms, including MAVA, EMRClaims+, and HealthPACER, which are pivotal in tech-enabled pharmaceutical commercialization.

Under the leadership of Founder and President Julian Casciano, the existing management team continues to play a critical role in eMAX’s strategic direction, with a significant investment stake in the company alongside Fengate Private Equity. The details of the transaction have not been disclosed.

Industry Overview in Canada

The healthcare industry in Canada is characterized by a robust framework that supports innovation and access to high-quality services. The increasing demand for real-world evidence and technology-driven solutions in healthcare has spurred growth in sectors